Resultaten ForFarmers over eerste halfjaar 2026: Voortzetting sterke resultaten, verdere groei marktaandeel

ForFarmers rapporteerde sterke H1 2026-cijfers: brutowinst steeg 12,6% naar €327,3 miljoen en onderliggende EBITDA nam 39,3% toe tot €84,7 miljoen, met onderliggende nettowinst +59,4% naar €37,3 miljoen (tegenover H1 2025). Operationeel genereerde het bedrijf €44,9 miljoen netto kasstroom uit activiteiten en rapporteerde een nettoschuld van €22,4 miljoen. Daarnaast kreeg ForFarmers goedkeuring van Poolse mededingingsautoriteiten voor de joint venture met KPS Food Group; afronding wordt in het najaar verwacht en het bedrijf kondigt nieuwe financiële doelstellingen aan tijdens een Capital Markets Day.

Analysis

ForFarmers (FFARM) is the kind of print that can support a rerating more than a one-day pop: the key signal is not just better earnings, but that scale is now translating into operating leverage while leverage remains negligible. In a low-margin feed business, a step-up in ROACE and a clean balance sheet matter because they give management room to consolidate a fragmented market without stressing equity holders.

The second-order winner is likely the company’s logistics and plant network in Poland/NL/DE, where incremental share gains can lift utilization faster than they lift gross volume. The clearest losers are smaller regional feed mills and cooperatives that lack purchasing power and can’t match service/innovation spend; if ForFarmers keeps taking share, pricing discipline in local markets could improve, but only if commodity inputs stay stable enough to avoid margin giveback.

The contrarian risk is that the market may overestimate how much of this is structural versus cyclical: autonomous volume was not accelerating, so some of the profit surge may be mix, price discipline, and easy comps rather than a permanently higher earnings base. The Poland JV is option value until closing and integration; any delay, softer poultry demand, or a reversal in grain/energy spreads would pressure the 1-3 month thesis. Over 6-18 months, the real catalyst is the Capital Markets Day—if they lift medium-term targets, the stock can re-rate; if not, it may revert to a lower multiple as a mundane ag-cycle name.

Key Decisions for Investors

• Accumulate FFARM on post-results pullbacks over the next 1-2 weeks; base case is a 3-6 month rerating into the year-end Capital Markets Day if autonomous volume stays non-negative and the Poland JV closes on schedule.
• If listed options are liquid, buy a 6-9 month FFARM call spread rather than outright stock to express upside to CMD while limiting downside if the market fades the print.
• Set a hard watch item on the next quarterly update: if autonomous volume turns negative or underlying EBITDA margin mean-reverts below the H1 run-rate, reduce exposure immediately; that would falsify the share-gain thesis.
• For a relative-value hedge, pair long FFARM against a basket of European small-cap industrials or domestic cyclicals if you want to isolate idiosyncratic agri consolidation upside rather than beta.
• Do not chase if the stock gaps materially on the release; the better entry is after the market confirms that Q3 volumes and the JV closing remain on track.